Jansen India Medtech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-07-2024
- Paid Up Capital ₹ 0.10 M
as on 05-07-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 10.73%
(FY 2023)
- Profit -265.97%
(FY 2023)
- Ebitda -183.70%
(FY 2023)
- Net Worth -238.50%
(FY 2023)
- Total Assets -19.50%
(FY 2023)
About Jansen India Medtech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jianyi Xu, Hui Xu, and Viswanathan Santhanagopalan serve as directors at the Company.
- CIN/LLPIN
U85300AP2019FTC113466
- Company No.
113466
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
22 Nov 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jansen India Medtech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viswanathan Santhanagopalan  | Director | 22-Nov-2019 | Current |
Jianyi Xu  | Director | 22-Nov-2019 | Current |
| Hui Xu | Director | 22-Nov-2019 | Current |
Financial Performance of Jansen India Medtech.
Jansen India Medtech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.73% increase. The company also saw a substantial fall in profitability, with a 265.97% decrease in profit. The company's net worth observed a substantial decline by a decrease of 238.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jansen India Medtech?
In 2023, Jansen India Medtech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ives Healthcare Private LimitedActive 14 years 9 monthsViswanathan Santhanagopalan is a mutual person
Sequoia Healthcare Private LimitedActive 6 years 4 monthsViswanathan Santhanagopalan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jansen India Medtech?
Unlock and access historical data on people associated with Jansen India Medtech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jansen India Medtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jansen India Medtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
